Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease
Gen-Ex
2 other identifiers
interventional
19
1 country
1
Brief Summary
The aging Veteran population, together with high exposure to Agent Orange or other herbicides during military service, has made diseases such as Parkinson's disease (PD), currently affecting more than 80,000 Veterans, a major health issue in the Veterans' health system. Mobility and cognitive limitations are a common problem in PD and are associated with significant disability, increased fall risk, reduced quality of life, and increased caregiver burden. While less is known about its benefit on cognition, physical therapy has proven to be an effective treatment to mitigate mobility limitations, though the response to rehabilitation interventions is highly variable. The proposed research will inform the investigators' understanding of the impact of certain genetic profiles associated with learning impairments on motor and cognitive benefits in response to gait rehabilitation, and will provide an important foundation for more personalized and improved gait rehabilitation programs for different subgroups of PD patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 24, 2018
CompletedFirst Posted
Study publicly available on registry
July 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedResults Posted
Study results publicly available
October 27, 2021
CompletedOctober 27, 2021
September 1, 2021
2.4 years
July 24, 2018
August 11, 2021
September 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Gait Speed (m/s)
The investigators will use the APDM Movement Monitoring system to assess gait speed (m/s) during straight-line walking as a measure of gait function.
measured at baseline, 2 weeks, 10 weeks and 16 weeks
Montreal Cognitive Assessment Score
The investigators will use the Montreal Cognitive Assessment (MoCA; score range=0-30, with 30 indicating better cognitive function) as a reflection of global cognitive function
measured at baseline and at 10 weeks
Study Arms (1)
Gait training
EXPERIMENTAL1 hour walking exercise on a treadmill
Interventions
Eligibility Criteria
You may not qualify if:
- Have a Hoehn \& Yahr score of 3
- Have the ability to walk 400 m without physical assistance from a device or another person
- Do not have other health conditions (e.g., orthopedic, cardiopulmonary) that impact the ability to safely participate in a moderately intense gait training program
- The investigators will exclude those patients presenting clinical diagnosis of dementia.
- The investigators will exclude those patients presenting conditions (cardiac, renal, or metabolic) that would pose a risk to their health by exercising.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Office of Research and Developmentlead
- University of Washingtoncollaborator
Study Sites (1)
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, 98108, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This trial was impacted by local and institutional restrictions on research implemented during the start of the COVID-19 pandemic. Restrictions on research activities impacted recruitment and impacted data collection for some participants.
Results Point of Contact
- Title
- Valerie E. Kelly, PT, PhD
- Organization
- University of Washington
Study Officials
- PRINCIPAL INVESTIGATOR
Ignacio Fernandez-Mata
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2018
First Posted
July 31, 2018
Study Start
February 1, 2018
Primary Completion
June 30, 2020
Study Completion
June 30, 2020
Last Updated
October 27, 2021
Results First Posted
October 27, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
We will not make individual participant data available.